Next Article in Journal
Inhibition of Cancer Derived Cell Lines Proliferation by Synthesized Hydroxylated Stilbenes and New Ferrocenyl-Stilbene Analogs. Comparison with Resveratrol
Previous Article in Journal
RBAP, a Rhodamine B-Based Derivative: Synthesis, Crystal Structure Analysis, Molecular Simulation, and Its Application as a Selective Fluorescent Chemical Sensor for Sn2+
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Design, Synthesis and Bioactivity of Novel Glycosylthiadiazole Derivatives

1
Department of Applied Chemistry, China Agricultural University, Beijing 100193, China
2
Department of Fundamental Science, Beijing University of Agriculture, Beijing 102206, China
3
Institute of Vegetables and Flowers, Chinese Academy of Agricultural Sciences, Beijing 100081, China
*
Authors to whom correspondence should be addressed.
The authors contributed equally to this paper.
Molecules 2014, 19(6), 7832-7849; https://doi.org/10.3390/molecules19067832
Submission received: 21 April 2014 / Revised: 4 June 2014 / Accepted: 5 June 2014 / Published: 11 June 2014

Abstract

:
A series of novel glycosylthiadiazole derivatives, namely 2-phenylamino-5-glycosyl-1,3,4-thiadiazoles, were designed and synthesized by condensation between sugar aldehydes A/B and substituted thiosemicarbazide C followed by oxidative cyclization by treating with manganese dioxide. The original fungicidal activities results showed that some title compounds exhibited excellent fungicidal activities against Sclerotinia sclerotiorum (Lib.) de Bary and Pyricularia oryzae Cav, especially compounds F-5 and G-8 which displayed better fungicidal activities than the commercial fungicide chlorothalonil. At the same time, the preliminary studies based on the Elson-Morgan method indicated that many compounds exhibited some inhibitory activity toward glucosamine-6-phosphate synthase (GlmS). The structure-activity relationships (SAR) are discussed in terms of the effects of the substituents on both the benzene and the sugar ring.

1. Introduction

Carbohydrates play an important role in the field of pesticide investigation, and many natural carbohydrate products used as pesticides have shown great vitality. Validamycin [1], validoxylamine A [2], trehazolin [3], streptomycin [4] and kasugamycin [5] have already proven excellent activities against pests and fungi, and most of them are considered to be non-toxic for mammals and have no adverse effects on non-target organisms or on the environment. Many natural products containing glycosyl residues in their structures, such as the derivatives of avermecin and spinosad, are well known green pesticides and widely used in the control of many kinds of pests, taking the advantage of excellent bioactivities, good environment compatibility and structure variability [6,7,8,9]. Encouraged by the successes of the developed commercial pesticides based on natural carbohydrates, pesticide chemists have paid considerable attention to the design, synthesis and activity evaluation of novel carbohydrate-containing compounds as potential pesticides, finding that heterocyclic compounds modified by carbohydrates exhibit excellent biological activities [10,11,12,13].
It is well established that 1,3,4-thiadiazole and their derivatives exhibit a broad spectrum of biological activities not only in research on drugs with anticancer [14], antimicrobial [15], antituberculosis [16], anticonvulsant [17], or anti-inflammatory activities [18,19] but also in pesticide research such as antifungal [20,21], insecticidal [22], herbicidal [23] and also plant growth regulating agents [24]. Consequently, studies on the synthesis and bioassays of 1,3,4-thiadiazole derivatives have attracted increasing attention in the field of pesticide discovery. As pesticides, many of the 1,3,4-thiadiazole derivatives showed high toxicity profiles and were taken off the market. Thus an interest in developing novel bioactive agents with low toxicities and an acceptable impact on the environment is increasing. One way to reach this goal is to modify the parent 1,3,4-thiadiazole structure.
In our previous studies [25,26,27], numerous 1,3,4-thiadiazole derivatives (I-III, Figure 1) were designed and synthesized. Some of them exhibited good fungicidal activity against Rhizoctonia solani Kühn, Verticillium dahlia Kleb. and Pyricularia oryzae Cav.
Figure 1. 1,3,4-Thiadiazole derivatives developed in our laboratory.
Figure 1. 1,3,4-Thiadiazole derivatives developed in our laboratory.
Molecules 19 07832 g001
Considering the advantages of using carbohydrates in developing novel pesticides, we made some efforts to investigate the antifungal activities of 1,3,4-thiadiazoles modified by carbohydrates, and a series of thiadiazoline derivatives containing glucofuranose were synthesized in our laboratory [28]. The fungicidal activity results obtained showed that compound IV (Figure 1) exhibited excellent fungicidal activities against Phytophtora parasitica Dast and Helminthosporium maydis Nisik & Miy. Inspired by these promising results, we developed a great interest in searching for potential 1,3,4-thiadiazole derivative pesticides containing furanoses. In the structure of compound IV, the 1,3,4-thiadiazole moiety and the glucofuranose moiety were connected in a spirocyclic manner. In particular the question of the kind of changes in the fungicidal activities that might happen if the two moieties were connected directly to each other (through a single bond) caught our attention. Thus, a series of xylose-based 1,3,4-thiadiazoles, were synthesized and evaluated, as mentioned in one of our former Chinese patents [29]. At the same time, as there is some similarity between the target compounds and the D-fructose-6-P, which is one of the substrates in the first committed step of the hexosamine biosynthesis pathway [30] by glucosamine-6-phosphate synthase (GlmS; EC 2.6.1.16), their enzyme inhibitory activities were evaluated, too. In this paper, we would like to report their synthesis (Scheme 1 and Scheme 2) and bioactivities in much greater details, and also their structure-activity relationship studies. Furthermore, to investigate the effects of the protecting groups in the sugar ring on the activities of compounds F and G, the deprotected compounds H, I and J were also synthesized and evaluated. We report herein the preliminary results of the study.

2. Results and Discussion

2.1. Synthesis of the Title Compounds

The synthesis of the target compounds was outlined in Scheme 1. According to the known methods [31,32,33], two furanosyl aldehydes (A and B) were prepared using D-glucose as the starting material.
Scheme 1. Synthesis of the target compounds F/G.
Scheme 1. Synthesis of the target compounds F/G.
Molecules 19 07832 g002
The substituted thiosemicarbazides C were synthesized from the corresponding substituted arylamines as previously described [24,31]. The condensation between furanosyl aldehydes A or B and substituted thiosemicarbazides C provided compounds D or E, respectively. Then the target compounds F or G were prepared by treating compounds D or E with MnO2. Compound H was obtained by deacetylation of compound F-8, and compounds I and J were obtained by deisopropylidenation of the related compounds F-8 and G-7, as shown in Scheme 2.
Scheme 2. Synthesis of the sugar moiety-modified compounds.
Scheme 2. Synthesis of the sugar moiety-modified compounds.
Molecules 19 07832 g003
All the derivatives were synthesized according to the procedures described in Scheme 1 and Scheme 2 in good overall yields of 65%–92%. The synthesized compounds were characterized by 1H-NMR, MS and HRMS. Most of the 1H-NMR experiments of compounds F and G were conducted in CDCl3 as the solvent. Nevertheless, the signal of NH was too weak in some cases, so we had to switch the solvent to DMSO-d6. The physical data of the target compounds are given in Table 1.
Table 1. Physical Data of Compounds F/G.
Table 1. Physical Data of Compounds F/G.
Compd.R1R2FormulaStatusm.p./°CYield (%)
F-1Ac4-Br-C6H4-C17H18BrN3O5SWhite foamy solid 204.1–204.779
F-2Ac4-CH3-C6H4-C18H21N3O5SWhite foamy solid187.9–188.182
F-3Ac4-CH3O-C6H4-C18H21N3O6Syellow foamy solid177.7–178.773
F-4Ac2,4-(CH3)2-C6H4-C19H23N3O5SWhite foamy solid133.7–134.381
F-5Ac3,4-Cl2-C6H4-C17H17Cl2N3O5SWhite foamy solid147.7–148.583
F-6Ac2,5-Cl2-C6H4-C17H17Cl2N3O5SWhite foamy solid61.8–62.985
F-7Ac1-Naphthyl-C21H21N3O5SWhite foamy solid57.0–58.165
F-8Ac4-Cl-3-CF3-C6H3-C18H17ClF3N3O5SWhite foamy solid140.0–141.277
F-9AcC6H4-C17H19N3O5SWhite foamy solid195.1–195.578
F-10Ac4-NO2-C6H4-C17H18N4O7Syellow foamy solid198.4–198.773
G-1All4-Br-C6H4-C18H20BrN3O4SWhite foamy solid204.1–204.768
G-2All4-CH3-C6H4-C19H23N3O4SWhite foamy solid187.9–188.174
G-3All4-CH3O-C6H4-C19H23N3O5SWhite foamy solid177.7–178.778
G-4All2,4-(CH3)2-C6H4-C20H25N3O4SWhite foamy solid133.7–134.376
G-5All3,4-Cl2-C6H4-C18H19Cl2N3O4SWhite foamy solid147.7–148.581
G-6All2,5-Cl2-C6H4-C18H19Cl2N3O4SWhite foamy solid61.8–62.976
G-7All1-Naphthyl-C22H23N3O4Syellow foamy solid57.0–58.168
G-8All4-Cl-3-CF3-C6H3-C19H19ClF3N3O4SWhite foamy solid140.0–141.286
G-9AllC6H4-C18H21N3O4SWhite foamy solid195.1–195.591
G-10All4-NO2-C6H4-C18H20N4O6SWhite foamy solid198.4–198.771

2.2. Fungicidal Activity of Compounds F/G against Six Fungus Species

Compounds F/G were evaluated in a series of in vitro fungicidal tests against six fungal species, and compared with the commercial fungicide chlorothalonil. As shown in Table 2, the resulting data revealed that most of the tested compounds displayed a certain degree of fungicidal activity against the six species. Among them, the majority of the compounds showed better fungicidal activity against S. sclerotiorum than the other five fungi. Among the 20 tested compounds, there were seven that displayed an inhibition rate of 90% or more against S. sclerotiorum at a concentration of 50 µg/mL. Therefore, the further activity evaluation of the compounds in our research was performed against S. sclerotiorum.
Table 2. Fungicidal activity of compounds F/G against six fungus species (% control at 50 µg/mL).
Table 2. Fungicidal activity of compounds F/G against six fungus species (% control at 50 µg/mL).
Compds No.S. sclerotiorumP. parasitica DastB. cinereaR. solani P. oryzae Cav.P. asparagi saecrdo
F-16811146029−8
F-2764050655235
F-380222670275
F-4843532695850
F-5912124677623
F-6949766777225
F-7886774627043
F-8893751534621
F-96827−11635654
F-1052126594125
G-1793072588026
G-2873279778115
G-3746550807966
G-4936188628751
G-5857484568584
G-6906377638798
G-7924285688566
G-8986480598371
G-9864064557985
G-10914381557857
Chlorothalonil9392841008294

2.3. Precise Fungicidal Activity of Compounds F/G Against S. sclerotiorum

The precise fungicidal activity of compounds F/G against S. sclerotiorum was evaluated, and the data are shown in Table 3. For half of the compounds F/G, i.e., 10 out of the 20 tested compounds, their EC50 values were <3 μg/mL. They thus exhibited good fungicidal activity against S. sclerotiorum. Among them, compounds F-5, F-8, G-5, G-6 and G-8 (the EC50 values of which are 0.29, 1.50, 1.50, 1.62 and 0.46 μg/mL, respectively) exhibited excellent fungicidal activity and they are comparable with the commercial fungicide chlorothalonil (with a EC50 value of 0.59 μg/mL).
Table 3. Fungicidal Activity of Compounds F/G against S. sclerotiorum.
Table 3. Fungicidal Activity of Compounds F/G against S. sclerotiorum.
Compds No.Regression eqrEC50 (μg/mL)EC90 (μg/mL)
F-1Y = 4.93 + 0.57x0.94161.33247.14
F-2Y = 3.96 + 1.39x0.98805.6447.03
F-3Y = 4.77 + 0.58x0.97912.45382.78
F-4Y = 4.11 + 1.04x0.97177.11120.46
F-5Y = 5.31 + 0.58x0.93490.2947.38
F-6Y = 3.93 + 1.80x0.97583.9420.30
F-7Y = 2.04 + 2.18x0.993722.5387.03
F-8Y = 4.80 + 1.11x0.95431.5021.6
F-9Y = 4.51 + 0.72x0.97984.70276.27
F-10Y = 4.13 + 0.56x0.976537.137558.45
G-1Y = 3.84 + 1.29x0.90598.0179.59
G-2Y = 3.94 + 1.58x0.99934.7030.32
G-3Y = 4.75 + 0.63x0.94572.51273.14
G-4Y = 2.48 + 2.52x0.98599.9231.89
G-5Y = 4.83 + 0.96x0.98801.5032.10
G-6Y = 4.80 + 0.94x0.98711.6237.28
G-7Y = 4.68 + 1.06x0.99402.0032.30
G-8Y = 5.34 + 0.99x0.99610.468.91
G-9Y = 4.32 + 1.26x0.98093.4435.81
G-10Y = 4.69 + 1.00x0.95342.0238.63
Chlorothalonil5.19 + 0.84x0.97840.5919.56
In general, the following structure-activity relationships (SAR) in compounds F/G were observed: (1) for the two series F and G, on an overall level the latter (R2 = allyl) displayed a better fungicidal activity than the former (R2 = Ac), i.e., there were six compounds in series G that exhibited better fungicidal activity than their counterparts in series F; (2) for the F series, the fungicidal activity is increased by improving the electron-withdrawing ability of substituents on the benzene ring, i.e., in compounds F-4 (R2 = 2,4-(CH3)2-C6H3-), F-2 (R2 = 4-CH3-C6H3-), F-9 (R2 = C6H3-), F-3 (R2 = 4-CH3O-C6H3-) and F-1 (R2 = 4-Br-C6H3-) with the EC50 values of 7.11, 5.64, 4.70, 2.45 and 1.33 μg/mL, respectively; (3) for the G series, the fungicidal activity is increased by improving the electron-withdrawing ability of substituents on the benzene ring, too, i.e., compounds G-4 (R2 = 2,4-(CH3)2-C6H3-), G-2 (R2 = 4-CH3-C6H3-), G-9 (R2 = C6H3-), G-3 (R2 = 4-CH3O-C6H3-) and G-6 (R2 = 2,5-Cl2-C6H3-) with the EC50 values of 9.92, 4.70, 3.44, 2.51 and 1.62 μg/mL, respectively; (4) In both series F and G, the compounds with two electron-withdrawing groups in the benzene ring have the best fungicidal activity in their own series, i.e., compounds F-5 (R2 = 3,4-Cl2-C6H3-) and G-8 (R2 = 4-Cl-3-CF3-C6H3-) with the EC50 values of 0.29 and 0.46 μg/mL, respectively. They were slightly better than the commercial fungicide chlorothalonil (EC50 value = 0.59 μg/mL). Similarly, compounds F-8 (R2 = 4-Cl-3-CF3-C6H3-) and G-5 (R2 = 3,4-Cl2-C6H3-), both with EC50 values of 1.50 μg/mL, also displayed excellent fungicidal activities. However, the compounds with two electron-donating groups in the benzene ring displayed only moderate fungicidal activity, i.e., compounds F-4 (R2 = 2,4-Me2-C6H3-) and G-4 (R2 = 2,4-Me2-C6H3-) with the EC50 values of 7.11 and 9.92 μg/mL, respectively.

2.4. Effect of Structure Modifications on the Sugar Ring around Compound F/G

Having identified the relatively potent compounds of series F/G, such as F-8, G-8 and G-7, we next focused our attention on investigating the effects of subtle structural changes in the sugar ring of compounds F/G. To this end, compounds H, I and J were prepared and evaluated. The fungicidal results against S. sclerotiorum are provided in Table 4. It is evident from the data (Table 3 and Table 4) that, among all the derivatives studied above, compounds with complete OH-protection in the sugar ring, i.e., compounds F-8, G-8 and G-7, displayed the most promising results, with the EC50 values of 1.50, 0.46, 2.00 μg/mL respectively. Meanwhile, compound H without the OH-protection at the 3-position in the sugar ring (and with an EC50 value of 4.61 μg/mL) has shown a slightly decreased fungicidal activity. Compounds I and J without the OH-protection at both 1 and 2-position displayed a significant decrease in their fungicidal activity, with EC50 values of 8.18, 18.91 μg/mL, respectively. The results above demonstrate that appropriate protections of the hydroxyl groups in the sugar ring can make positive contributions to the fungicidal activity against S. Sclerotiorum. Interestingly, however, the enzyme inhibitory activity of compounds H, I and J is superior to that of compound G-8 (Table 5), which may be associated with a better structural similarity between fructose 6-phosphate (Fru-6-P) and compounds H, I and J.
Table 4. Effects of structural modifications in sugar ring of compounds F/G on the activity against S. sclerotiorum. Molecules 19 07832 i001
Table 4. Effects of structural modifications in sugar ring of compounds F/G on the activity against S. sclerotiorum. Molecules 19 07832 i001
Compds No.Regression eqrEC50EC90
HY = 4.40 + 0.91x0.86784.61119.37
IY = 4.27 + 0.80x0.99638.18321.93
JY = 2.80 + 1.72x0.922818.91105.14
Table 5. Enzyme inhibition Rate of Compounds F and G at 0.35 mm.
Table 5. Enzyme inhibition Rate of Compounds F and G at 0.35 mm.
Compd No.Inhibition Rate (%)Compd No.Inhibition Rate (%)
F-113.2G-112.0
F-215.3G-210.8
F-317.7G-316.1
F-418.5G-415.2
F-518.3G-525.8
F-619.1G-617.4
F-717.9G-728.1
F-818.1G-826.5
F-914.7G-920.3
F-1013.3G-1024.2
H29.4J36.2
I35.8

2.5. Bioassay of Enzyme Inhibitory Activities [34,35,36,37]

Inhibitory activity of all the synthesized compounds towards Candida albicans GlcN-6-P synthase was evaluated using the optimized Elson-Morgan method [38]. The absorption value of the solution was measured at 585 nm, and then the concentration was counted by the specification curve which was determined thanks to the relation between the absorption value and the concentration of glucosamine-6-phosphate. Finally the enzyme inhibition rate was calculated according to Equation (1):
Molecules 19 07832 i002
In Equation (1): I is the inhibition rate, Molecules 19 07832 i003 is the average concentration of glucosamine-6-phosphate in the blank test, and Molecules 19 07832 i004 is the average concentration of glucosamine-6-phosphate in the presence of target compounds. The inhibition rates were given in Table 5 at 0.35 mm.
The compounds of series F and G exhibited some enzyme inhibitory activities (Table 5). Compounds G-5, G-7, G-8 and G-10 are more active against glucosamine-6-phosphate synthase than the other compounds. On the whole, the enzyme inhibitory activity of G series of compounds is superior to the F series. The enzyme inhibitory activity of compounds H, I and J is superior to that of compound G-8 (Table 5), which may be associated with a better structural similarity between fructose 6-phosphate (Fru-6-P) and compounds H, I and J.

3. Experimental

3.1. General Methods

All starting materials and reagents were commercially available and used without further purification except as indicated. 1H-NMR (300 MHz) and 13C-NMR (75 MHz) spectra was recorded in CDCl3 or DMSO-d6 with a Bruker DPX300 spectrometer, using TMS as internal standard; Mass spectra were obtained with Agilent 1100 series LC/MSD mass spectrometer. High-resolution mass spectra (HRMS) was performed by the Peking University. Melting points were measured on a Yanagimoto melting-point apparatus and are uncorrected.

3.2. Chemical Synthesis

General Procedure for the Syntheses of Title Compounds F, G, H, I and J. Substituted aldehydes A and B were prepared from D-glucose as the starting material according to known methods [20,21,22]. Substituted thiosemicarbazides C were synthesized from amines as previously described [33,39].
General Procedure for the Synthesis of Intermediate Compounds D/E. A solution of aldehyde A/B (5.5 mmol) and thiosemicarbazide C (5 mmol) in CH2Cl2 (100 mL) was heated to reflux for 6 h, at the end of which time TLC (eluent: 2:1 petroleum ether-EtOAc) indicated that the reaction was complete. The solvent was evaporated under diminished pressure at 40 °C to give a white solid, and the crude product was used for next step directly without purification.
General Procedure for the Synthesis of Title Compounds F/G. To a stirred solution of compound D/E (5.0 mmol) in CHCl3 (80 mL) was added MnO2 (10 g). The mixture was stirred for a further 1 h, at the end of which time TLC (eluent: 2:1 petroleum ether-EtOAc) indicated that the reaction was complete. After filtration, the filtrate was evaporated under reduced pressure to give a crude product, which was purified on silica gel column chromatography with 4:1 petroleum ether-EtOAc as the eluent to give the compounds F/G.
2-(4-Bromophenylamino)-5-(2R,3S-O-isopropylidene-4S-O-acetyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (F-1). Yield: 79%. White solid, mp 239.1–240.2 °C. 1H-NMR (DMSO-d6): δ 10.61 (s, 1H, NH), 7.62 (d, J = 8.9 Hz, 2H, ArH), 7.52 (d, J = 8.9 Hz, 2H, ArH), 6.07 (d, J = 3.7 Hz, 1H, H-1), 5.54 (d, J = 3.0 Hz, 1H, H-3), 5.28 (d, J = 3.0 Hz, 1H, H-4), 4.79 (d, J = 3.7 Hz, 1H, H-2), 2.02 (s, 3H, CH3CO), 1.52, 1.31 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 168.82, 165.18, 154.23, 139.71, 131.74, 119.36, 113.27, 111.85, 104.36, 82.63, 76.51, 76.30, 26.33, 25.93, 20.61. ESI-MS m/z calcd. for C17H17BrN3O5S (M-H) 454.0. Found: 454.0. HRMS for C17H19BrN3O5S [M+H]+ 456.0223. Found: 456.0212.
2-(4-Tolylamino)-5-(2R,3S-O-isopropylidene-4S-O-acetyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (F-2). Yield: 82%. Pale-yellow solid, mp 227.6–228.0 °C. 1H-NMR (CDCl3): δ 10.42 (br, 1H, NH), 7.33-7.27 (m, 2H, ArH), 7.19 (m, 2H, ArH), 6.03 (d, J = 3.6 Hz, 1H, H-1), 5.72 (d, J = 3.1 Hz, 1H, H-3), 5.48 (d, J = 3.1 Hz, 1H, H-4), 4.65 (d, J = 3.7 Hz, 1H, H-2), 2.34 (s, 3H Ar-CH3), 2.00 (s, 3H, CH3CO), 1.59, 1.36 (2s, 6H, Me2C); 13C-NMR (CDCl3) δ 169.01, 138.05, 133.25, 130.13, 118.45, 112.86, 104.77, 83.30, 77.26, 76.92, 26.75, 26.22, 20.79. ESI-MS m/z calcd. for C18H21N3NaO5S (M+Na) 414.1. Found: 414.2. HRMS for C18H22N3O5S [M+H]+ 392.1275. Found: 392.1275.
2-(4-Methoxyphenylamino)-5-(2R,3S-O-isopropylidene-4S-O-acetyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazols (F-3). Yield: 73%. Yellow solid, mp 186.7–188.0 °C. 1H-NMR (DMSO-d6): δ 10.28 (br, 1H, NH), 7.52 (d, J = 8.9 Hz, 2H, ArH), 6.93 (d, J = 8.9 Hz, 2H, ArH), 6.05 (d, J = 3.8 Hz, 1H, H-1), 5.50 (d, J = 3.0 Hz, 1H, H-3), 5.26 (d, J = 3.1 Hz, 1H, H-4), 4.76 (d, J = 3.8 Hz, 1H, H-2), 3.73 (s, 3H, Ar-CH3O), 2.02 (s, 3H, CH3CO), 1.51, 1.30 (2s, 6H, Me2C); 13C-NMR (CDCl3) δ 169.08, 156.67, 133.90, 121.40, 114.97, 112.97, 104.83, 83.34, 77.29, 77.00, 55.61, 26.81, 26.29, 20.88. ESI-MS m/z calcd. for C18H22N3O6S [M+H] 408.1. Found: 408.1. HRMS for C18H22N3O6S [M+H]+ 408.1224. Found: 408.1218.
2-(2,4-Dimethylphenylamino)-5-(2R,3S-O-isopropylidene-4S-O-acetyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazols (F-4). Yield: 81%. White solid, mp 155.9–156.1 °C. 1H-NMR (CDCl3): δ 7.79 (br, 1H, NH), 7.29 (d, J = 8.0 Hz, 1H, ArH), 7.10–7.00 (m, 2H, ArH), 5.97 (d, J = 3.6 Hz, 1H, H-1), 5.65 (d, J = 3.1 Hz, 1H, H-3), 5.43 (d, J = 3.1 Hz, 1H, H-4), 4.61 (d, J = 3.7 Hz, 1H, H-2), 2.32 (2s, 6H, Ar-CH3), 1.98 (s, 3H, CH3CO), 1.56, 1.34 (2s, 6H, Me2C); 13C-NMR (CDCl3) δ 172.26, 168.97, 152.98, 137.24, 136.09, 132.52, 132.10, 127.69, 123.01, 112.83, 104.71, 83.26, 77.28, 76.93, 26.75, 26.25, 20.93, 20.78, 17.89. ESI-MS m/z calcd. for C19H24N3O5S [M+H] 406.1. Found: 406.1. HRMS for C19H24N3O5S [M+H]+ 406.1431. Found: 406.1422.
2-(3,4-Dichlorophenylamino)-5-(2R,3S-O-isopropylidene-4S-O-acetyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (F-5). Yield: 83%. White solid, mp 232.6–235.0 °C. 1H-NMR (DMSO-d6): δ 10.79 (s, 1H, NH), 8.07 (d, J = 2.5 Hz, 1H, ArH), 7.59 (d, J = 8.8 Hz, 1H, ArH), 7.49 (dd, J = 8.9, 2.5 Hz, 1H, ArH), 6.08 (d, J = 3.7 Hz, 1H, H-1), 5.56 (d, J = 3.1 Hz, 1H, H-3), 5.30 (d, J = 3.1 Hz, 1H, H-4), 4.79 (d, J = 3.8 Hz, 1H, H-2), 2.02 (s, 3H, CH3CO), 1.52, 1.31 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 168.81, 164.87, 154.87, 140.24, 131.30, 130.72, 123.15, 118.55, 117.53, 111.88, 104.40, 82.63, 76.47, 76.29, 26.32, 25.91, 20.59. ESI-MS m/z calcd. for C17H18Cl2N3O5S [M+H] 446.0. Found: 446.1. HRMS for C17H18Cl2N3O5S [M+H]+ 446.0339. Found: 446.0330.
2-(2,5-Dichlorophenylamino)-5-(2R,3S-O-isopropylidene-4S-O-acetyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (F-6). Yield: 85%. White solid, mp 119.6–120.6 °C. 1H-NMR (CDCl3): δ 8.22 (d, J = 2.3 Hz, 1H, ArH), 7.69 (s, 1H, NH), 7.33 (d, J = 8.5 Hz, 1H, ArH), 7.00 (dd, J = 8.5, 2.4 Hz, 1H, ArH), 6.05 (d, J = 3.6 Hz, 1H, H-1), 5.73 (d, J = 3.1 Hz, 1H, H-3), 5.50 (d, J = 3.1 Hz, 1H, H-4), 4.68 (d, J = 3.6 Hz, 1H, H-3), 2.04 (s, 3H, CH3CO), 1.59, 1.36 (2s, 6H, Me2C); 13C-NMR (CDCl3) δ 169.02, 165.30, 156.89, 137.41, 133.82, 130.28, 123.74, 120.59, 119.02, 113.09, 104.92, 83.30, 77.18, 77.04, 26.80, 26.27, 20.83. ESI-MS m/z calcd. for C17H18Cl2N3O5S [M+H] 446.0. Found: 446.1. HRMS for C17H18Cl2N3O5S [M+H]+ 446.0339. Found: 446.0329.
2-(Naphthalen-1-ylamino)-5-(2R,3S-O-isopropylidene-4S-O-acetyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (F-7). Yield: 65%. Pale-yellow solid, mp 186.1–186.9 °C. 1H-NMR (DMSO-d6): δ 10.36 (s, 1H, NH), 8.25 (m, 1H, ArH), 8.13 (d, J = 7.5 Hz, 1H, ArH), 7.96 (m, 1H, ArH), 7.72 (d, J = 8.2 Hz, 1H, ArH), 7.64–7.50 (m, 3H, ArH), 6.06 (d, J = 3.8 Hz, 1H, H-1), 5.54 (d, J = 3.1 Hz, 1H, H-3), 5.29 (d, J = 3.1 Hz, 1H, H-4), 4.78 (d, J = 3.8 Hz, 1H, H-2), 2.01 (s, 3H, CH3CO), 1.52, 1.30 (2s, 6H, Me2C); 13C-NMR (75 MHz, DMSO-d6) δ 168.83, 167.94, 153.96, 136.33, 133.93, 128.33, 126.21, 126.01, 125.95, 125.90, 124.06, 121.99, 117.28, 111.79, 104.30, 82.61, 76.59, 76.28, 26.32, 25.92, 20.61. ESI-MS m/z calcd. for C21H22N3O5S [M+H] 428.1. Found: 428.1. HRMS for C21H22N3O5S [M+H]+ 428.1275. Found: 428.1263.
2-(4-Chloro-3-(trifluoromethyl)phenylamino)-5-(2R,3S-O-isopropylidene-4S-O-acetyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (F-8). Yield: 77%. Pale-yellow solid, mp 219.8–221.5 °C. 1H-NMR (DMSO-d6): δ 10.95 (s, 1H, NH), 8.25 (d, J = 2.5 Hz, 1H, ArH), 7.86 (dd, J = 8.8, 2.5 Hz, 1H, ArH), 7.69 (d, J = 8.8 Hz, 1H, ArH), 6.09 (d, J = 3.7 Hz, 1H, H-1), 5.57 (d, J = 3.1 Hz, 1H, H-3), 5.30 (d, J = 3.1 Hz, 1H, H-4), 4.80 (d, J = 3.7 Hz, 1H, H-2), 2.02 (s, 3H, CH3CO), 1.52, 1.31 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 168.84, 164.88, 155.12, 139.63, 132.26, 126.99 (q, J = 30.7 Hz), 124.53, 122.25 (d, J = 1.7 Hz), 122.11, 120.91, 116.03 (q, J = 5.5 Hz), 111.91, 104.43, 82.63, 76.39 (d, J = 11.6 Hz), 26.32, 25.92, 20.57. ESI-MS m/z calcd. for C18H18ClF3N3O5S [M+H] 480.1. Found: 480.1. HRMS for C18H18ClF3N3O5S [M+H]+ 480.0602. Found: 480.0588.
2-(Phenylamino)-5-(2R,3S-O-isopropylidene-4S-O-acetyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (F-9). Yield: 78%. Pale-yellow solid, mp 213.7–214.1 °C. 1H-NMR (DMSO-d6): δ 10.63 (s, 1H, NH), 7.41-7.39 (m, 4H, ArH), 7.11 (m, 1H, ArH), 6.04 (d, J = 3.6 Hz, 1H, H-1), 5.74 (d, J = 3.1 Hz, 1H, H-3), 5.51 (d, J = 3.1 Hz, 1H, H-4), 4.66 (d, J = 3.7 Hz, 1H, H-2), 2.00 (s, 3H, CH3CO), 1.60, 1.36 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 168.84, 165.55, 153.68, 140.43, 129.05, 121.97, 117.43, 111.82, 104.33, 82.62, 76.54, 76.30, 26.32, 25.93, 20.61. ESI-MS m/z calcd. for C17H20N3O5S [M+H] 378.1. Found: 378.1. HRMS for C17H20N3O5S [M+H]+ 378.1118. Found: 378.1109.
2-(4-Nitrophenylamino)-5-(2R,3S-O-isopropylidene-4S-O-acetyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (F-10). Yield: 73%. Pale-yellow solid, mp 233.9–235.5 °C. 1H-NMR (DMSO-d6): δ 11.22 (s, 1H, NH), 8.27 (d, J = 8.7 Hz, 2H, ArH), 7.85 (d, J = 8.7 Hz, 2H, ArH), 6.10 (d, J = 3.4 Hz, 1H, H-1), 5.59 (d, J = 2.6 Hz, 1H, H-3), 5.32 (d, J = 2.6 Hz, 1H, H-4), 4.80 (d, J = 3.5 Hz, 1H, H-2), 2.02 (s, 3H, CH3CO), 1.53, 1.31 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 168.62, 164.27, 155.82, 145.85, 140.67, 125.20, 116.75, 111.69, 104.22, 82.40, 76.22, 76.07, 26.10, 25.71, 20.36. ESI-MS m/z calcd. for C17H17N4O7S (M-H) 421.1. Found: 421.0. HRMS for C17H19N4O7S [M+H]+ 423.0969. Found: 423.0957.
2-(4-Bromophenylamino)-5-(2R,3S-O-isopropylidene-4S-O-allyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazol (G-1). Yield: 68%. Pale-yellow solid, mp 204.1–204.7 °C. 1H-NMR (CDCl3): δ 10.50 (br, 1H, NH), 7.49-7.46 (m, 2H, ArH), 7.36-7.26 m, 2H, ArH), 6.04 (d, J = 3.6 Hz, 1H, H-1), 5.72 (m, 1H, CH2=CHCH2), 5.63 (d, J = 3.1 Hz, 1H, H-3), 5.23-5.14 (m, 2H, CH2=CHCH2), 4.69 (d, J = 3.7 Hz, 1H, H-2), 4.15 (d, J = 3.2 Hz, 1H, H-4), 4.04-3.86 (m, 2H, CH2=CHCH2), 1.58, 1.37 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 165.56, 155.14, 139.84, 134.03, 131.70, 119.28, 117.15, 113.08, 111.47, 111.39, 104.44, 81.82, 81.78, 77.57, 70.44, 26.52, 25.96. ESI-MS m/z calcd. for C18H19BrN3O4S (M-H) 452.0. Found: 451.9. HRMS for C18H21BrN3O4S [M+H]+ 454.0431. Found: 454.0415.
2-(4-Tolylamino)-5-(2R,3S-O-isopropylidene-4S-O-allyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (G-2). Yield: 74%. Pale-yellow solid, mp 187.9–188.1 °C. 1H-NMR (CDCl3): δ 9.39 (br, 1H, NH), 7.29–7.26 (m, 2H, ArH), 7.18-7.16 (m, 2H, ArH), 6.02 (d, J = 3.7 Hz, 1H, H-1), 5.73 (m, 1H, CH2=CHCH2), 5.62 (d, J = 3.1 Hz, 1H, H-3), 5.23-5.13 (m, 2H, CH2=CHCH2), 4.67 (d, J = 3.6 Hz, 1H, H-2), 4.14 (d, J = 3.1 Hz, 1H, H-4), 4.02–3.85 (m, 2H, CH2=CHCH2), 2.33 (s, 3H, Ar-CH3), 1.56, 1.36 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 166.13, 154.21, 138.20, 134.08, 130.77, 129.40, 117.46, 117.11, 111.34, 104.40, 81.81, 77.62, 70.42, 26.53, 25.96, 20.28. ESI-MS m/z calcd. for C19H24N3O4S [M+H] 390.1. Found: 390.1. HRMS for C19H24N3O4S [M+H]+ 390.1482. Found: 390.1468.
2-(4-Methoxyphenylamino)-5-(2R,3S-O-isopropylidene-4S-O-allyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (G-3). Yield: 78%. Pale-yellow solid, mp 177.7–178.7 °C. 1H-NMR (CDCl3): δ 9.70 (br, 1H, NH), 7.35–7.26 (m, 2H, ArH), 6.93–6.90 (m, 2H, ArH), 6.01 (d, J = 3.5 Hz, 1H, H-1), 5.72 (m, 1H, CH2=CHCH2), 5.59 (d, J = 3.0 Hz, 1H, H-3), 5.22–5.13 (m, 2H, CH2=CHCH2), 4.66 (d, J = 3.6 Hz, 1H, H-2), 4.13 (d, J = 3.0 Hz, 1H, H-4), 4.01–3.85 (m, 2H, CH2=CHCH2), 3.81 (s, 3H, Ar-CH3O), 1.56, 1.35 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 166.58, 154.53, 153.85, 134.12, 134.08, 119.21, 117.11, 114.26, 111.35, 104.39, 81.83, 77.65, 70.43, 55.19, 26.52, 25.96. ESI-MS m/z calcd. for C19H24N3O5S [M+H] 406.1. Found: 406.2. HRMS for C19H24N3O5S [M+H]+ 406.1431. Found: 406.1417.
2-(2,4-Dimethylphenylamino)-5-(2R,3S-O-isopropylidene-4S-O-allyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (G-4). Yield: 76%. Pale-yellow solid, mp 133.7–134.3 °C. 1H-NMR (CDCl3): δ 9.41 (s, 1H, NH), 7.58 (d, J = 9.0 Hz, 1H, ArH), 7.04–6.99 (m, 2H, ArH), 5.96 (d, J = 3.7 Hz, 1H, H-1), 5.82 (m, 1H, CH2=CHCH2), 5.53 (d, J = 3.1 Hz, 1H, H-3), 5.22–5.10 (m, 2H, CH2=CHCH2), 4.79 (d, J = 3.7 Hz, 1H, H-2), 4.07 (d, J = 3.1 Hz, 1H, H-4), 4.12–3.87 (m, 2H, CH2=CHCH2), 2.25, 2.21 (2s, 6H, Ar-CH3), 1.46,1.29 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 168.89, 154.03, 136.75, 134.08, 133.48, 131.25, 129.92, 127.02, 122.20, 117.03, 111.29, 104.33, 81.83, 77.67, 70.40, 26.51, 25.95, 20.34, 17.72. ESI-MS m/z calcd. for C20H26N3O4S [M+H] 404.1. Found: 404.1. HRMS for C20H26N3O4S [M+H]+ 404.1639. Found: 404.1624.
2-(3,4-Dichlorophenylamino)-5-(2R,3S-O-isopropylidene-4S-O-allyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (G-5). Yield: 81%. Pale-yellow solid, mp 147.7–148.5 °C. 1H-NMR (CDCl3): δ 10.77 (s, 1H, NH), 7.59 (s, 1H, ArH), 7.44 (m, 1H, ArH), 7.34 (m, 1H, ArH), 6.06 (d, J = 3.5 Hz, 1H, H-1), 5.74 (m, 1H, CH2=CHCH2), 5.65 (s, 1H, H-3), 5.24–5.15 (m, 2H, CH2=CHCH2), 4.71 (d, J = 3.5 Hz, 1H, H-2), 4.42–3.82 (m, 3H, H-4, CH2=CHCH2), 1.59, 1.38 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 165.25, 155.74, 140.37, 134.01, 131.25, 130.73, 122.95, 118.44, 117.48, 117.16, 111.41, 104.47, 81.79, 81.75, 77.50, 70.42, 26.51, 25.94. ESI-MS m/z calcd. for C18H20Cl2N3O4S [M+H] 444.0. Found: 444.0. HRMS for C18H20Cl2N3O4S [M+H]+ 444.0546. Found: 444.0526.
2-(2,5-Dichlorophenylamino)-5-(2R,3S-O-isopropylidene-4S-O-allyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (G-6). Yield: 76%. Pale-yellow solid, mp 61.8–62.9 °C. 1H-NMR (CDCl3): δ 8.21 (m, 1H, ArH), 7.73 (br, 1H, NH), 7.30 (m, 1H, ArH), 6.98 (m, 1H, ArH), 6.05 (d, J = 3.6 Hz, 1H, H-1), 5.74 (m, 1H, CH2=CHCH2), 5.63 (d, J = 3.2 Hz, 1H, H-3), 5.25–5.16 (m, 2H, CH2=CHCH2), 4.70 (d, J = 3.6 Hz, 1H, H-2), 4.18 (d, J = 3.2 Hz, 1H, H-4), 4.05–3.87 (m, 2H, CH2=CHCH2), 1.57, 1.37 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 165.69, 157.21, 138.18, 134.05, 132.07, 130.79, 122.92, 120.35, 119.94, 117.16, 111.42, 104.50, 81.83, 77.66, 70.45, 26.52, 25.96. ESI-MS m/z calcd. for C18H20Cl2N3O4S [M+H] 444.0. Found: 444.0. HRMS for C18H20Cl2N3O4S [M+H]+ 444.0546. Found: 444.0527.
2-(Naphthalen-1-ylamino)-5-(2R,3S-O-isopropylidene-4S-O-allyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (G-7). Yield: 68%. Pale-yellow solid, mp 57.0–58.1 °C. 1H-NMR (CDCl3): δ 10.28 (br, 1H, NH), 8.23 (m, 1H, ArH), 8.12 (m, 1H, ArH), 7.95 (m, 1H, ArH), 7.00 (m, 1H, ArH), 7.58-7.49 (m, 3H, ArH), 5.98 (d, J = 3.6 Hz, 1H, H-1), 5.78 (m, 1H, CH2=CHCH2), 5.37 (d, J = 3.1 Hz, 1H, H-3), 5.22–5.10 (m, 2H, CH2=CHCH2), 4.81 (d, J = 3.7 Hz, 1H, H-2), 4.14–3.64 (m, 3H, H-4, CH2=CHCH2), 1.48, 1.30 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 168.27, 154.99, 136.47, 134.05, 133.94, 128.30, 126.18, 126.03, 125.93, 125.83, 123.88, 122.04, 117.10, 111.36, 104.42, 81.85, 77.71, 70.44, 26.53, 25.97. ESI-MS m/z calcd. for C22H24N3O4S [M+H] 426.1. Found: 426.1. HRMS for C22H24N3O4S [M+H]+ 426.1482. Found: 426.1462.
2-(4-Chloro-3-(trifluoromethyl)phenylamino)-5-(2R,3S-O-isopropylidene-4S-O-allyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (G-8). Yield: 86%. Pale-yellow solid, mp 140.0–141.2 °C. 1H-NMR (CDCl3): δ 10.54 (s, 1H, NH), 7.81 (m, 1H, ArH), 7.63-7.48 (m, 2H, ArH), 6.05 (d, J = 3.5 Hz, 1H, H-1), 5.74 (m, 1H, CH2=CHCH2), 5.64 (d, J = 3.1 Hz, 1H, H-3), 5.24–5.15 (m, 2H, CH2=CHCH2), 4.71 (d, J = 3.5 Hz, 1H, H-2), 4.17 (d, J = 3.0 Hz, 1H, H-4), 4.07–3.87 (m, 2H, CH2=CHCH2), 1.59, 1.38 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 165.26, 155.95, 139.76, 134.01, 132.21, 126.96 (q, J = 30.6 Hz), 124.53, 122.06 (d, J = 1.9 Hz), 122.01, 120.91, 117.13, 115.94 (q, J = 5.6 Hz), 111.44, 104.51, 81.81 (d, J = 2.1 Hz), 77.53, 70.45, 26.50, 25.93. ESI-MS m/z calcd. for C19H20ClF3N3O4S [M+H] 478.1. Found: 478.2. HRMS for C19H20ClF3N3O4S [M+H]+ 478.0810. Found: 478.0802.
2-(Phenylamino)-5-(2R,3S-O-isopropylidene-4S-O-allyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (G-9). Yield: 91%. Pale-yellow solid, mp 195.1–195.5 °C. 1H-NMR (CDCl3): δ 10.66 (s, 1H, NH), 7.46–7.35 (m, 4H, ArH), 7.09 (m, 1H, ArH), 6.04 (d, J = 3.6 Hz, 1H, H-1), 5.73 (m, 1H, CH2=CHCH2), 5.65 (d, J = 3.1 Hz, 1H, H-3), 5.23–5.13 (m, 2H, CH2=CHCH2), 4.69 (d, J = 3.6 Hz, 1H, H-2), 4.16 (d, J = 3.1 Hz, 1H, H-4), 4.13–3.86 (m, 2H, CH2=CHCH2), 1.58, 1.37 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 165.96, 154.62, 140.58, 134.06, 129.01, 121.80, 117.35, 117.11, 111.37, 104.43, 81.82, 77.62, 70.43, 26.52, 25.97. ESI-MS m/z calcd. for C18H21N3O4SNa (M+Na) 398.1. Found: 398.1. HRMS for C18H22N3O4S [M+H]+ 376.1326. Found: 376.1323.
2-(4-Nitrophenylamino)-5-(2R,3S-O-isopropylidene-4S-O-allyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (G-10). Yield: 71%. Pale-yellow solid, mp 198.4–198.7 °C. 1H-NMR (CDCl3): δ 11.75 (s, 1H, NH), 8.33–8.28 (m, 2H, ArH), 7.62–7.57 (m, 2H, ArH), 6.08 (d, J = 3.6 Hz, 1H, H-1), 5.80–5.69 (m, 2H, CH2=CHCH2, H-3), 5.25–5.15 (m, 2H, CH2=CHCH2), 4.74 (d, J = 3.7 Hz, 1H, H-2), 4.21 (d, J = 3.2 Hz, 1H, H-4), 4.16-3.89 (m, 2H, CH2=CHCH2), 1.62, 1.40 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 164.86, 156.82, 146.19, 140.78, 134.00, 125.32, 117.16, 116.84, 111.48, 104.55, 81.85, 81.79, 77.54, 70.49, 26.49, 25.91. ESI-MS m/z calcd. for C18H21N4O6S [M+H] 421.1. Found: 421.1. HRMS for C18H21N4O6S [M+H]+ 421.1176. Found: 421.1173.
2-(4-Chloro-3-(trifluoromethyl)phenylamino)-5-(2R,3S-O-isopropylidene-4S-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (H). To a solution of F-8 (0.48 g, 1.0 mmol) in MeOH (20 mL) was added MeONa (0.05 g). The reaction mixture was stirred at rt for 0.5 h, at the end of which time TLC (1:2 petroleum ether–EtOAc) indicated that the reaction was complete. Neutralization of the reaction mixture with acidic ion exchange resin (Amberlite IR-120 (H+), Alfa Aesar, Tianjin, China) was conducted, and the organic phase was concentrated under reduced pressure to give a crude product, which could be purified by recrystallization from a mixture solvents of petroleum ether (10 mL) and EtOAc (2 mL). Yield: 92%. White solid, mp 249.8–250.3 °C. 1H-NMR (DMSO-d6): δ 10.84 (s, 1H, NH), 8.26 (d, J = 2.5 Hz, 1H, ArH), 7.86 (dd, J = 2.5, 8.8 Hz, 2H, ArH), 7.68 (d, J = 8.8 Hz, 1H, ArH), 6.01 (d, 1H, J = 3.6 Hz, H-1), 5.98 (d, J = 5.2 Hz, 1H, OH), 5.33 (d, J = 2.7 Hz, 1H, H-4), 4.60 (d, J = 3.6 Hz, 1H, H-2), 4.68 (dd, J = 3.6 Hz, 5.2 Hz, 1H, H-3), 1.48, 1.29 (2s, 6H, Me2C); 13C-NMR (DMSO-d6) δ 165.13, 156.93, 139.88, 132.26, 127.00 (q, J = 30.7 Hz), 124.58, 121.97, 120.96, 115.93 (q, J = 5.6 Hz), 111.33, 104.52, 84.86, 78.49, 74.58, 26.66, 26.01. ESI-MS m/z calcd. for C16H16ClF3N3O4S [M+H] 438.0. Found: 438.0. HRMS for C16H16ClF3N3O4S [M+H]+ 438.0497. Found: 438.0478.
2-(4-Chloro-3-(trifluoromethyl)phenylamino)-5-(3S,4S-O-acetyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (I). A solution of F-8 (0.48 g, 1.0 mmol) and CF3COOH (9 mL) and H2O (1 mL) was stirred at rt for 12 h, at the end of which time TLC (1:2 petroleum ether-EtOAc) indicated that the reaction was complete. The reaction mixture was neutralized with solid NaHCO3, and filtered through Celite. The filtrate was evaporated under reduced pressure to give a crude product, which was purified on silica gel column chromatography with 1:1 petroleum ether-EtOAc as the eluent to give the compound. Yield: 79%. Pale-yellow solid, mp 115.6–116.5 °C. 1H-NMR (DMSO-d6): δ 10.87 (d, J = 12.2 Hz, 1H, NH), 8.26 (d, J = 2.6 Hz, 1H, ArH), 7.83 (dd, J = 2.6, 8.8 Hz, 2H, ArH), 7.68 (d, J = 8.8 Hz, 1H, ArH), 7.05 (br, 1H, OH), 5.89 (br, 1H, OH), 5.55–5.52 (m, 1H, H-1), 5.40–5.26 (m, 1H, H-3), 5.19–5.17 (m, 1H, H-4), 4.13–4.00 (m, 1H, H-2), 1.92 (s, 3H, OCH3). ESI-MS m/z calcd. for C15H12ClF3N3O5S (M-H) 438.0. Found: 438.0. HRMS for C15H14ClF3N3O5S [M+H]+ 440.0289. Found: 440.0272.
2-(Naphthalen-1-ylamino)-5-(3S,4S-O-acetyl-tetrahydrofuro-2,3,4-triol-5S)-1,3,4-thiadiazole (J). Deisopropylidenation of G-7 (0.52 g, 1.2 mmol) was accomplished by following the same procedure employed for the preparation of compound J. Yield: 73%. Yellow solid, mp 57.2–59.7 °C. 1H-NMR (DMSO-d6): δ 10.19 (s, 1H, NH), 8.24–8.22 (m, 1H, ArH), 8.09 (d, J = 7.4 Hz, 1H, ArH), 7.97–7.94 (m, 1H, ArH), 7.70 (d, J = 8.1 Hz, 1H, ArH), 7.58–7.49 (m, 3H, ArH), 6.62 (d, J = 5.5 Hz, 0.5H), 6.51 (d, J = 7.3 Hz, 0.5H), 5.77–5.70 (m, 1H, CH2=CHCH2), 5.57 (d, J = 4.3 Hz, 0.5H), 5.43–5.28 (m, 2H), 5.20–5.05 (m, 2.5H), 4.01–3.87 (m, 4H). ESI-MS m/z calcd. for C19H20N3O4S [M+H] 386.1. Found: 386.0. HRMS for C19H20N3O4S [M+H]+ 386.1169. Found: 386.1169.

3.3. Fungicidal Assays

Each of the test compounds was dissolved in DMSO (10 mL). Fungicidal activities of compounds F, G, H, I and J against Sclerotinia sclerotiorum (Lib.) de Bary, Phytophthora parasitica Dast, Botrytis cinerea Pers., Rhizoctonia solani Kühn., Pyricularia oryzae Cav. and Phoma asparagi Saecrdo were evaluated using the mycelium growth rate test as previously reported [40].
Inhibition rates of compounds F and G against S. sclerotiorum, P. Parasitica Dast, B. cinerea, R solani, P. oryzae Cav and P. asparagi Saecrdo at 50 μg/mL were determined first and the results are given in Table 2. The inhibition rate of compounds F, G, H, I and J against S. sclerotiorum were further determined at the concentrations of 50, 20, 10, 5 and 2 μg/mL, respectively. Then EC50 and EC90 values were estimated using logit analysis [41]. The commercial fungicide chlorothalonil was used as a control in the above bioassay.

3.4. Enzyme Inhibitory Activities Bioassay

Inhibitory activities of all the synthesized compounds towards Candida albicans GlcN-6-P synthase were evaluated using the mycelium growth rate test as previously reported [38]. Three replicates were performed. Absorbance at λ = 585 nm was measured and GlcN-6-P concentration in the sample was read from the standard curve (solutions of glucosamine-HCl (0.1–1 mM) were assayed simultaneously, to obtain a standard line from the plot of extinction against concentration of glucosamine). In each experiment, two control samples, one without enzyme and one without substrates, were assayed in the same way.

4. Conclusions

In summary, a series of novel glycosylthiadiazole derivatives were synthesized, and their bioactivities were evaluated. The bioassays showed that they had the inhibitory activities against glucosamine-6-phosphate synthase, and at the same time, the results from the Chinese Academy of Agricultural Science have shown that most of the tested compounds have good fungicidal activities against S. sclerotiorum. Among all the novel compounds tested, compounds F-5 and G-8 displayed better fungicidal activities than the commercial fungicide chlorothalonil. The SAR of the designed compounds was studied: compounds with two electron-withdrawing substituents in the benzene ring have better fungicidal activities than those with two electron-donating substituents. The compounds with the protecting groups in the sugar ring have less inhibitory activities against Glms than those without protecting groups, but displayed better fungicidal activities against S. sclerotiorum, and the advantage depends on the number and type of the protection groups. Further studies are in progress.

Supplementary Materials

Supplementary materials can be accessed at: https://www.mdpi.com/1420-3049/19/6/7832/s1.

Acknowledgments

We acknowledge financial support of this investigation by NSFC of China (21172257), the National High Technology Research and Development Programme of China (2011AA10A206), the National Basic Research Program of China (2010CB126105, 2011BAE06B02-01, 2012BAK25B03-01) and Key laboratory of Horticultural Crops Genetic Improvenment, Ministry of Agriculture in China.

Author Contributions

Main text paragraph Guanghui Zong was in charge of the synthesis experiments, Hanqing Zhao was in charge of bioassay, they wrote the manuscript together; Rui Jiang provided help in the synthesis experiments and bioassay experiments; 1H and 13C-NMR spectra were tested by Xiaomei Liang; Jianjun Zhang provided guidance and suggestions for all the experiments and he also provided proper suggestions when wrote and revised the manuscript; Daoquan Wang provided guidance and suggestions in the synthesis experiments. Yanxia Shi and Baoju Li provided guidance and suggestions in the bioassay experiments.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Horii, S.; Kameda, Y.; Kawahara, K. Studies on validamycins, new antibiotics. VIII. Validamycins C, D, E and F. J. Antibiot. 1972, 25, 48–53. [Google Scholar] [CrossRef]
  2. Asano, N.; Takeuchi, M.; Kameda, Y.; Matsui, K.; Kono, Y. Trehalase inhibitors, validoxylamine A and related compounds as insecticides. J. Antibiot. 1990, 43, 722–726. [Google Scholar] [CrossRef]
  3. Kyosseva, S.V.; Kyossev, Z.N.; Elbein, A.D. Elbein, Inhibitors of pig kidney trehalase. Arch. Biochem. Biophys. 1995, 316, 821–826. [Google Scholar] [CrossRef]
  4. Schatz, A.; Bugie, E.; Waksman, S.A. Streptomycin, a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria. Proc. Soc. Exp. Biol. Med. 1944, 55, 66–69. [Google Scholar] [CrossRef]
  5. Hamada, M.; Hashimoto, T.; Takahashi, T.; Yokoyama, S.; Miyake, M.; Takeuchi, T.; Okami, Y.; Umezawa, H.A. Antimicrobial activity of kasugamycin. J. Antibiot. Ser. A 1965, 18, 104–106. [Google Scholar]
  6. Geopffrey, H.; Davis, I. Avermectins and milbemycins Part I. Chem. Soc. Rev. 1991, 20, 211–260. [Google Scholar] [CrossRef]
  7. Chabala, J.C.; Fisher, M.H. Selective Hydrogenation Products of C-076 Compounds and Derivatives Thereof. U.S. Patent 4,199,569, 22 4 1980. [Google Scholar]
  8. Mrozik, H.; Eskola, P.; Linn, B.O.; Lusi, A.; Shih, T.L.; Tischler, M.; Waksmunski, F.S.; Wyvratt, M.J.; Hilton, N.J. Discovery of novel avermectins with unprecedented insecticidal activity. Experientia 1989, 45, 315–316. [Google Scholar] [CrossRef]
  9. Gary, D.; Thomapson, R.D.; Thomas, C.S. Spinosad-a case study: An example from a natural products discovery programme. Pest. Manag. Sci. 2000, 56, 696–702. [Google Scholar] [CrossRef]
  10. Da Rocha, D.R.; Santos, W.C.; Lima, E.S.; Ferreira, V.F. Synthesis of 1,2,3-triazole glycoconjugates as inhibitors of α-glucosidases. Carbohydr. Res. 2012, 350, 14–19. [Google Scholar]
  11. Zhang, P.; Wei, C.; Wang, E.; Wang, W.; Liu, M.; Yin, Q.; Chen, H.; Wang, K.; Li, X.; Zhang, J. Synthesis and biological activities of novel isoxazoline-linked pseudo-disaccharide derivatives. Carbohydr. Res. 2012, 351, 7–16. [Google Scholar]
  12. Chen, H.; Jiao, L.; Guo, Z.; Li, X.; Ba, C.; Zhang, J. Synthesis and biological activity of novel thiazolidin-4-ones with a carbohydrate moiety. Carbohydr. Res. 2008, 343, 3015–3020. [Google Scholar]
  13. Bokor, E.; Docsa, T.; Gergely, P.; Somsak, L. Synthesis of 1-(-glucopyranosyl)-1,2,3-triazoles and their evaluation as glycogen phosphorylase inhibitors. Bioorg. Med. Chem. 2010, 18, 1171–1180. [Google Scholar] [CrossRef]
  14. Noolvi, M.; Patel, H.; Singh, N.; Gadad, A.; Cameotra, S.; Badiger, A. Synthesis and anticancer evaluation of novel 2-cyclopropylimidazo[2,1-b] [1,3,4]-thiadiazole derivatives. Eur. J. Med. Chem. 2011, 46, 4411–4418. [Google Scholar] [CrossRef]
  15. Shen, X.; Zhong, H.; Zheng, H.; Zhang, H.; Zhao, G.; Wu, Q.; Mao, H.; Wang, E.; Zhu, Y. Crystal structure, thermal decomposition kinetics and antimicrobial activities of [Zn(eatz)2(OAc)2] (eatz=5-ethyl-2-amino-1,3,4-thiadiazole). Polyhedron 2004, 23, 1851–1857. [Google Scholar] [CrossRef]
  16. Oruc, E.; Rollas, S.; Kandemirli, F.; Shvets, N.; Dimoglo, A. 1,3,4-Thiadiazole derivatives. Synthesis, structure elucidation, and structure-antituberculosis activity relationship investigation. J. Med. Chem. 2004, 47, 6760–6767. [Google Scholar] [CrossRef]
  17. Pattanayak, P.; Sharma, R. 2-Amino-5-sulphanyl-1,3,4-thiadiazole derivatives as anticonvulsant agents: Synthesis and evaluation. Indian J. Chem. B. 2011, 49B, 1531–1534. [Google Scholar]
  18. Kadi, A.; Al-Abdullah, E.; Shehata, I.; Habib, E.; Ibrahim, T.; El-Emam, A. Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives. Eur. J. Med. Chem. 2010, 45, 5006–5011. [Google Scholar] [CrossRef]
  19. Schenone, S.; Brullo, C.; Bruno, O.; Bondavalli, F.; Ranise, A.; Filippelli, W.; Rinaldi, B.; Capuano, A.; Falcone, G. New 1,3,4-thiadiazole derivatives endowed with analgesic and anti-inflammatory activities. Bioorg. Med. Chem. 2006, 14, 1698–1705. [Google Scholar]
  20. Chen, C.; Song, B.; Yang, S.; Xu, G.; Bhadury, P.S.; Jin, L.; Hu, D.; Li, Q.; Liu, F.; Xue, W.; et al. Synthesis and antifungal activities of 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-thiadiazole and 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-oxadiazole derivatives. Bioorg. Med. Chem. 2007, 15, 3981–3989. [Google Scholar]
  21. Niewiadomy, A.; Matysiak, J. Fungicidal evaluation of substituted 4-(1,3,4-thiadiazol-2-yl) benzene-1,3-diols. Pestycydy 2011, 1–4, 5–14. [Google Scholar]
  22. Wan, R.; Zhang, J.; Han, F.; Wang, P.; Yu, P.; He, Q. Synthesis and insecticidal activities of novel 1,3,4-thiadiazole 5-fluorouracil acetamides derivatives: An RNA interference insecticide. Nucleos. Nucleot. Nucleic Acids 2011, 30, 280–292. [Google Scholar] [CrossRef]
  23. Wang, T.; Miao, W.; Wu, S.; Bing, G.; Zhang, X.; Qin, Z.; Yu, H.; Qin, X.; Fang, J. Synthesis, crystal structure, and herbicidal activities of 2-cyanoacrylates containing 1,3,4-thiadiazole moieties. Chin. J. Chem. 2011, 29, 959–967. [Google Scholar] [CrossRef]
  24. Chen, C.; Zhang, Z.; Du, M.; Wang, S.; Wang, Y. Synthesis of N-[[(5-mercapto-1,3,4-thiadiazol-2-yl)amino]carbonyl]benzamide and 2-(phenoxy)-N-[[(5-mercapto-1,3,4-thiadiazol-2-yl)amino]carbonyl]acetamide derivatives and determination of their activity as plant growth regulators. Chin. J. Org. Chem. 2007, 27, 1444–1447. [Google Scholar]
  25. Chen, L.; Wang, D.; Jin, S. Synthesis and fungicidal activity of 2-(1,11-undecylidene)-5-substituted imino-Δ3–1,3,4-thiadiazolines. Chin. J. Appl. Chem. 2002, 19, 212–215. [Google Scholar]
  26. Yang, X.; Jin, S.; Yang, C.; Wang, D. Synthesis and fungicidal activity of 2-(1,5-pentamethylene)-5-substituted imino-Δ3-1,3,4-thiadiazolines. Chin. J. Pest. Sci. 2004, 6, 22–25. [Google Scholar]
  27. Li, J.; Liang, X.; Jin, S.; Zhang, J.; Yuan, H.; Qi, S.; Chen, F.; Wang, D. Synthesis, fungicidal activity, and structure-activity relationship of spiro-compounds containing macrolactam (macrolactone) and thiadiazoline rings. J. Agric. Food Chem. 2010, 58, 2659–2663. [Google Scholar]
  28. Zhang, J.; Wang, D.; Yan, S.; Liang, X.; Wu, J. Preparation of Thiadiazoline and Furan Ring-Containing Spirocyclic Compounds as Fungicides. CN 101624396, 13 1 2010. [Google Scholar]
  29. Zhang, J.; Zong, G.; Liang, X.; Wang, D. Preparation of Furanosyl-Modified 1,3,4-thiadiazole Derivatives as Agricultural Bactericides. CN 102153602, 24 2 2011. [Google Scholar]
  30. Durand, P.; Golinelli-Pimpaneau, B.; Mouilleron, S.; Badet, B.; Badet-Denisot, M.A. Highlights of glucosamine-6P synthase catalysis. Arch. Biochem. Biophys. 2008, 474, 302–317. [Google Scholar]
  31. Zou, X.J.; Lai, L.H.; Jin, G.Y.; Zhang, Z.X. Synthesis, fungicidal activity, and 3D-QSAR of pyridazinone-substituted 1,3,4-oxadiazoles and 1,3,4-thiadiazoles. J. Agric. Food Chem. 2002, 50, 3757–3760. [Google Scholar] [CrossRef]
  32. Kalidhar, U.; Kaur, A. 1,3,4-Thiadiazole derivatives and their biological activities: A review. Res. J. Pharm. Biol. Chem. Sci. 2011, 2, 1091–1106. [Google Scholar]
  33. Han, M.J.; Yoo, K.S.; Kim, Y.H.; Chang, J.Y. Polymeric enzyme mimics: Catalytic activity of ribose-containing polymers for a phosphate substrate. Org. Biomol. Chem. 2003, 1, 2276–2282. [Google Scholar] [CrossRef]
  34. Olchowy, J.; Kur, K.; Sachadyn, P. Construction, purification, and functional characterization of his-tagged candida albicans glucosamine-6-phosphate synthase expressed in escherichia coli. Protein Expr. Purif. 2006, 46, 309–315. [Google Scholar] [CrossRef]
  35. Chittur, S.V.; Griffith, R.K. Multisubstrate analogue inhibitors of glucosamine-6-phosphate synthase from candida albicans. Bioorg. Med. Chem. Lett. 2002, 12, 2639–2642. [Google Scholar] [CrossRef]
  36. Bearne, S.L. Active site-directed inactivation of escherichia coli glucosamine-6-phosphate synthase. J. Biol. Chem. 1996, 271, 3052–3057. [Google Scholar]
  37. Dias, D.F.; Roux, C.; Durand, P.; Iorga, B.; Badet-Denisot, M.A.; Badet, B.; Alves, R.J. Design, synthesis and In Vitro evaluation on glucosamine-6P synthase of aromatic analogs of 2-aminohexitols-6P. J. Braz. Chem. Soc. 2010, 21, 680–685. [Google Scholar] [CrossRef]
  38. Zhao, H.Q.; Zhou, M.J.; Duan, L.F.; Wang, W.; Zhang, J.J.; Wang, D.Q.; Liang, X.M. Efficient Synthesis and Anti-Fungal Activity of Oleanolic Acid Oxime Esters. Molecules 2013, 18, 3615–3629. [Google Scholar] [CrossRef]
  39. Kaliappan, K.P.; Kumar, N. Efficient metathesis route to the B-ring of eleutherobin and other medium-sized cyclic ethers. Tetrahedron 2005, 61, 7461–7469. [Google Scholar] [CrossRef]
  40. Tisler, M. Syntheses in the 4-substituted thiosemicarbazide series. Croat. Chem. Acta 1956, 28, 147–154. [Google Scholar]
  41. Li, X.H.; Yang, X.L.; Ling, Y.; Fan, Z.J.; Liang, X.M.; Wang, D.Q.; Chen, F.H.; Li, Z.M. Synthesis and fungicidal activity of novel 2-oxocycloalkylsulfonylureas. J. Agric. Food Chem. 2005, 53, 2202–2206. [Google Scholar] [CrossRef]
  • Sample Availability: Samples of the compounds C-5, C-6, C-8, F-8 and G-8 are available from the authors.

Share and Cite

MDPI and ACS Style

Zong, G.; Zhao, H.; Jiang, R.; Zhang, J.; Liang, X.; Li, B.; Shi, Y.; Wang, D. Design, Synthesis and Bioactivity of Novel Glycosylthiadiazole Derivatives. Molecules 2014, 19, 7832-7849. https://doi.org/10.3390/molecules19067832

AMA Style

Zong G, Zhao H, Jiang R, Zhang J, Liang X, Li B, Shi Y, Wang D. Design, Synthesis and Bioactivity of Novel Glycosylthiadiazole Derivatives. Molecules. 2014; 19(6):7832-7849. https://doi.org/10.3390/molecules19067832

Chicago/Turabian Style

Zong, Guanghui, Hanqing Zhao, Rui Jiang, Jianjun Zhang, Xiaomei Liang, Baoju Li, Yanxia Shi, and Daoquan Wang. 2014. "Design, Synthesis and Bioactivity of Novel Glycosylthiadiazole Derivatives" Molecules 19, no. 6: 7832-7849. https://doi.org/10.3390/molecules19067832

Article Metrics

Back to TopTop